| Aktienanzahl | 2,08 Mio. |
| Aktientyp | ADR |
Zahlen für Q3/21
- Management believes that ASLAN’s cash and cash equivalents will be sufficient to fund operations through late 2023
https://ir.aslanpharma.com/news-releases/news-release-details/aslan-pharmaceuticals-reports-third-quarter-2021-financial